How we transform portfolio companies
Regulated healthcare demands more than capital or oversight. It requires experienced leadership embedded within the business, with a deep understanding of its operational, regulatory and commercial complexities.
Parami’s team takes active executive roles within portfolio companies and remain closely involved in day-to-day operations. From stabilising the business and defining its strategic direction to building capabilities, developing portfolios, forging partnerships and expanding markets, they take direct responsibility for execution and remain accountable for outcomes.
Following acquisition, we refine the investment thesis into a clear strategic roadmap, setting priorities across the portfolio, capabilities, partnerships, operations and markets.
From day one, we safeguard business continuity and regulatory standing while strengthening governance, compliance, financial control and operational discipline.
Implementing cost structure improvements, manufacturing efficiency programmes, quality system upgrades, and supply chain restructuring.
Building manufacturing capacity, advancing product pipelines, and entering new regulated markets to capture commercial growth opportunities.
Developing leadership teams, management systems, and governance processes required to support long-term scalability as a standalone platform.
Develop a clear value-creation roadmap from the outset and translate it into sequenced, executable initiatives across portfolio development, capability building, partnerships, acquisitions and market expansion.
Sterile manufacturing, aseptic processing, lyophilisation, fill-finish, complex oral solid dosage, and cleanroom device assembly deep technical knowledge and unit economics across every modality.
FDA, EMA, WHO and ISO 13485 navigation remediation, new filings, technology transfers, design control and inspection management, and compliance programme design and execution.
Global API and excipient sourcing, vendor qualification, demand planning, and logistics structured for resilience, cost efficiency, and continuity of supply.
Pricing strategy, tender management, customer relationships, and channel partnerships for hospital, retail, and institutional pharmaceutical markets globally.
End-to-end transaction execution for carve-outs, platform acquisitions, and bolt-ons including diligence, structuring, regulatory continuity, and 100-day integration.
Building world-class pharmaceutical leadership teams from our deep industry network with incentive structures aligned to long-term value creation.
